» Articles » PMID: 31692873

Esophageal 3D Organoids of Mouse Model of Mitochondrial DNA Depletion Show Epithelial Cell Plasticity and Telomere Attrition

Overview
Journal Oncotarget
Specialty Oncology
Date 2019 Nov 7
PMID 31692873
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Esophageal squamous cell carcinoma (ESCC) is an aggressive cancer with late-stage detection and poor prognosis. This emphasizes the need to identify new markers for early diagnosis and treatment. Altered mitochondrial genome (mtDNA) content in primary tumors correlates with poor patient prognosis. Here we used three-dimensional (3D) organoids of esophageal epithelial cells (EECs) from the mouse model of mtDNA depletion to investigate the contribution of reduced mtDNA content in ESCC oncogenicity. To test if mtDNA defects are a contributing factor in ESCC, we used oncogenic stimuli such as ESCC carcinogen 4-nitroquinoline oxide (4-NQO) treatment, or expressing p53 oncogenic driver mutation. We observed that EECs and 3D-organoids with mtDNA depletion had cellular, morphological and genetic alterations typical of an oncogenic transition. Furthermore, mitochondrial dysfunction induced cellular transformation is accompanied by elevated mitochondrial fission protein, DRP1 and pharmacologic inhibition of mitochondrial fission by mDivi-1 in the organoids reversed the phenotype to that of normal EEC organoids. Our studies show that mtDNA copy number depletion, activates a mitochondrial retrograde response, potentiates telomere defects, and increases the oncogenic susceptibility towards ESCC. Furthermore, mtDNA depletion driven cellular plasticity is mediated via altered mitochondrial fission-fusion dynamics.

Citing Articles

Evaluation of the efficacy of mitochondrial fission inhibitor (Mdivi-1) using non-alcoholic steatohepatitis (NASH) liver organoids.

Elbadawy M, Tanabe K, Yamamoto H, Ishihara Y, Mochizuki M, Abugomaa A Front Pharmacol. 2023; 14:1243258.

PMID: 37900170 PMC: 10600465. DOI: 10.3389/fphar.2023.1243258.


Single cell transcriptomic analysis reveals cellular diversity of murine esophageal epithelium.

Kabir M, Karami A, Cruz-Acuna R, Klochkova A, Saxena R, Mu A Nat Commun. 2022; 13(1):2167.

PMID: 35443762 PMC: 9021266. DOI: 10.1038/s41467-022-29747-x.

References
1.
Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, dAdamo P, Calvo S . MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 2006; 38(5):570-5. DOI: 10.1038/ng1765. View

2.
Xie Q, Wu Q, Horbinski C, Flavahan W, Yang K, Zhou W . Mitochondrial control by DRP1 in brain tumor initiating cells. Nat Neurosci. 2015; 18(4):501-10. PMC: 4376639. DOI: 10.1038/nn.3960. View

3.
Okawa T, Michaylira C, Kalabis J, Stairs D, Nakagawa H, Andl C . The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation. Genes Dev. 2007; 21(21):2788-803. PMC: 2045132. DOI: 10.1101/gad.1544507. View

4.
Trifunovic A, Larsson N . Tissue-specific knockout model for study of mitochondrial DNA mutation disorders. Methods Enzymol. 2002; 353:409-21. DOI: 10.1016/s0076-6879(02)53065-2. View

5.
He Y, Wu J, Dressman D, Iacobuzio-Donahue C, Markowitz S, Velculescu V . Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature. 2010; 464(7288):610-4. PMC: 3176451. DOI: 10.1038/nature08802. View